Assessing Diagnostic and Treatment Gaps for Cryptococcal Meningitis and Histoplasmosis in Sub-Saharan Africa.
A healthcare organization seeking to understand the current and future landscape of cryptococcal meningitis (CM) and histoplasmosis (Histo) testing and patient management in Sub-Saharan Africa.
.svg)
The client needed in-depth insights into healthcare provider (HCP) perspectives to optimize diagnostic and treatment strategies. The gaps in testing availability, treatment pathways, and disease management persist.
Cryptococcal meningitis (CM) and histoplasmosis (Histo) are life-threatening fungal infections that disproportionately affect advanced HIV patients. For that, we conducted a specialized healthcare market research study across South Africa, Nigeria, and Kenya to assess:
Current testing practices and availability of diagnostics for CM and Histo.
Challenges faced by infectious disease specialists in managing these conditions.
Future expectations for disease management and treatment accessibility.
Target Respondents: Infectious disease specialists actively treating relevant patient groups. (Sample Size: 8 respondents per country).
Moderation: Conducted by experienced moderators familiar with HCP discussions on invasive fungal infections and treatment pathways.
Data Collection: In-depth qualitative interviews to explore diagnostic barriers, treatment challenges, and areas for improvement.
.svg)
Identified key barriers to early diagnosis, including limited availability of rapid testing for CM and Histo.
Highlighted treatment challenges, such as delays in antifungal access and inconsistent clinical guidelines.
Provided insights into expected advancements in patient management, including potential adoption of newer diagnostic tools.
Equipped the client with strategic recommendations to improve testing accessibility and streamline patient care.
.svg)
“The in-depth research carried out by ZACRAC has been invaluable to us. Understanding the challenges healthcare providers face in diagnosing and managing cryptococcal meningitis and histoplasmosis has given us the clarity needed to refine our strategies and improve access to testing and treatment for at-risk patients in the region”.
.svg)
Client
Ready to Launch with Confidence?
Contact us today for a free consultation.